What are Vascular Imaging Devices?
Vascular imaging devices are used in diagnosing vascular-related diseases by viewing vascular tissues. The increasing prevalence of diabetes and hypertension are responsible to drive the growth of the market. Also, due to the technological advancements the devices are non-invasive and are used by several radiologists to identify vascular anatomy.
What is the market for Global Vascular Imaging Devices?
Global Vascular Imaging Devices Marketwas valued at USD 7.73 billion in 2020, growing at a CAGR of 5.51% during the forecast period from 2021 to 2026, to reach USD 10.61 billion by 2026.
What are the drivers for Global Vascular Imaging Devices?
The major drivers driving the demand for Vascular Imaging Devices are the prevalence of a vast number of patients suffering from vascular-related diseases like hypertension, arrhythmias, and diabetes, additionally, vascular imaging devices were found to be extremely beneficial in COVID-19 cases in the pandemic situation.
For more information on Vascular Imaging Market, click here @ https://www.delveinsight.com/report-store/vascular-imaging-market-market
What are the key players operating in Global Vascular Imaging Devices?
Some of the key market players operating in the Vascular Imaging Devices market include Siemens Healthineers, GE Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Samsung Medison, Shimadzu Corporation, St. Jude Medical, Inc., TERUMO Corporation, Koninklijke Philips N.V., Hologic, Inc., Esaote SpA, Carestream Health, Inc. and others.
What regions have the highest share in the Vascular Imaging Devices market?
North America is expected to dominate the overall Vascular Imaging Devices market during the forecast period, 2021 to 2026. This domination is due to the growing demand for advanced technologies in these devices, the increasing vascular diseases in the region are driving the regional growth. Additionally, high capital expenditure like building super-specialty Hospitals and Surgical centers is expected to boost the market growth.
Recent Developmental Activities in the Vascular Imaging Devices Market:
- In August 2021, Abbott Laboratories received the US Food and Drug Administration (FDA) go-ahead for its latest optical coherence tomography (OCT) imaging platform, powered by the company's new Ultreon Software. The Ultreon Software is first-of-its-kind imaging software that combines OCT with artificial intelligence (AI). The United States’ clearance for the OCT imaging platform closely follows the attainment of CE Mark for the same in Europe.
- In August 2021, Pulse Medical Imaging Technology (Shanghai) Co. Ltd. has raised more than USD 100 million in a Series C funding round to accelerate the R&D, clinical trials, and commercialization of its products. Pulse plans to use the funds to accelerate the commercialization of its fractional flow reserve (FFR) estimating systems. FFR is a method to measure blood pressure and flow within a coronary artery to check on the possibility that the stenosis impedes oxygen delivery to the heart muscle.
- In August 2021, Trivitron has recently launched SonoRad V60 Ultrasound, devoted to delivering excellent imaging systems and exceptional image quality.
Request sample report of Vascular Imaging Market @ https://www.delveinsight.com/sample-request/vascular-imaging-market-market